bioRxiv Science⌕ Search

Biology subjects

Uzonna, J. E.

Publications and source records attributed to Uzonna, J. E..

3 recordsLinked to original sources

Persistent antigen is essential for sustaining Leishmania-specific memory CD4+ T cells and long-term immunity

Memory T cells are critical for secondary immunity against pathogens, yet their persistence in the absence of antigen remains unclear. While memory CD8+ T cells are known to persist independently of their cognate antigen, the durability of memory CD4+ T cells in the absence of antigen remains controversial. Recovery from cutaneous leishmaniasis confers lifelong immunity, largely mediated by CD4+ T cells, but the necessity of persistent parasites for sustaining this immunity has not been empirically confirmed. We investigated immunity in mice infected with a dihydrofolate reductase-thymidylate synthase (dhfr-ts)-deficient Leishmania major, which cannot persist due to their thymidine salvage deficiency. These mice lost protection against wild-type challenge, correlating with a decline in Leishmania (PEPCK)-specific CD4+ T cells. To further dissect this relationship, we generated PEPCK-specific CD4+ TCR transgenic (PEG) mice, enabling precise tracking of Leishmania-specific memory CD4+ T cells. Both in vitro and in vivo-generated memory PEG cells gradually disappeared over time in the absence of antigen, irrespective of the hosts MHC II status, and this loss paralleled the erosion of infection-induced immunity. PEG and endogenous PEPCK-specific memory cells were not maintained in mice infected with dhfr-ts- or PEPCK-deficient L. major, resulting in loss of recall responses and secondary immunity. These findings demonstrate that continuous antigen presence is crucial for maintaining Leishmania-specific memory CD4+ T cells and highlight the role of persistent antigen in sustaining long-term immunity against chronic infections.

immunology↗

Assessment of autophagy in Leishmania parasites

Leishmaniasis is a neglected tropical disease caused by numerous species of Leishmania parasites, including Leishmania major. The parasite is transmitted by several species of sandfly vectors and infects myeloid cells leading to a myriad of inflammatory responses, immune dysregulations, and disease manifestations. Every cell undergoes autophagy, a self-regulated degradative process that permits the cells to recycle damaged or worn-out organelles in order to maintain cellular health and homeostasis. Studies have shown that Leishmania modulates their host cell autophagic machinery and there are indications that the parasite-specific autophagic processes may be valuable for parasite virulence and survival. However, the role of autophagy in Leishmania is inconclusive because of the limited tools available to study the Leishmania-specific autophagic machinery. Here, we describe methods to study and definitively confirm autophagy in Leishmania major. Transmission electron microscopy (TEM) allowed us to visualize Leishmania autophagosomes, especially those containing damaged mitochondrial content, as well as dividing mitochondria with ongoing fusion/fission processes. Flow cytometry enabled us to identify the amount of acridine orange dye accumulating in the acidic vacuolar compartments in Leishmania major by detecting fluorescence in the red laser when autophagic inhibitors or enhancers were included. These methods will advance studies that aim to understand autophagic regulation in Leishmania parasites that could provide insights into developing improved therapeutic targets against leishmaniasis.

cell biology↗

The Long Pentraxin 3 (PTX3) Suppresses Immunity to Cutaneous Leishmaniasis by Negatively Regulating Th17 Response

The long Pentraxin 3 (PTX3), a soluble pattern recognition molecule, plays a critical role in inflammation, tissue repair and wound healing. Here, we show that PTX3 regulates disease pathogenesis in cutaneous leishmaniasis (CL). PTX3 expression is increased in active skin lesions in patients and mice during CL, with higher levels being expressed in individuals with severe disease. PTX3 deficient (PTX3-/-) mice were highly resistant to L. major infection and the enhanced resistance was associated with increased IL-17 response. Neutralization of IL-17A abolished this enhanced resistance while treatment with recombinant PTX3 resulted in reduced IL-17A response and increased susceptibility to L. major infection. Naive CD4+ T cells from PTX3-/- mice displayed increased differentiation into Th17 cells, which was reversed in the presence of recombinant PTX3. The enhanced Th17 response observed in PTX3-/- cells was associated with increased Leishmania specific IL-6 production from dendritic cells along with enhanced expression of Th17-specific transcription factors including ROR{gamma}t, AhR and STAT3. Addition of recombinant PTX3 significantly inhibited the expression of Th17-specific transcription factors and dramatically reduced the frequency of Th17 cells in Th17-polarizing cultures of PTX3-/- CD4+ T cells. Collectively, our results show that PTX3 contributes to the pathogenesis of CL by suppressing Th17 differentiation and IL-17A production.\n\nAuthor SummaryCutaneous leishmaniasis (CL) is caused by several species of Leishmania. Currently, there is no approved vaccine against human CL because of the poor understanding of the mechanisms that regulate disease pathogenesis and correlates of protective immunity. Because the long pentraxin 3 (PTX3, a soluble pattern recognition molecule that forms an integral part of the host innate immunity), regulates inflammation and tissue repair, which are critical physiological events associated with resolution of skin lesions during CL, we investigated its role in disease pathogenesis.\n\nHere, we show that PTX3 levels were elevated in skin-lesions in patients and mice during CL. Using a loss of function approach, we showed that PTX3 contributes to pathogenesis, and this was associated with increased IL-17A responses. Neutralization and recombinant cytokine treatment studies showed that the increased resistance of PTX3 deficient mice to L. major is due to enhanced Th17 response in these mice. We further show that PTX3 negatively regulates IL-6 production by dendritic cells and the expression of IL-17A-specific transcription factors (including ROR{gamma}T, STAT3, IRF4, BATF and AhR) in CD4+ T cells. Collectively, these findings show that PTX3 is a negative regulator of Th17 response and protective immunity during L. major infection.

immunology↗